武汉永璨生物科技有限公司
+86-17702719238 sales@sun-shinechem.com

NLG919(GDC0919)

编号: 52246
Cas号: 1402836-58-1
纯度: 98% 

NLG919 is a promising and potent direct enzymatic inhibitor of IDO,In preclinical models, NLG919 showed dose dependent activation and proliferation of effector T cells, producing dramatic regression of large established tumors. Additionally, NLG919 showed enhanced immune activation and tumor regression when combined with Indoximod in this system.

Reference:
1.J Immunother Cancer. 2014; 2(Suppl 3): P250. Published online 2014 Nov 6. doi:  10.1186/2051-1426-2-S3-P250
   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292544/

 

仅供研究使用。 我们不向患者出售。

化学信息

名称NLG919(GDC0919)
Iupac 化学名称1-cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol 
同义词NLG 919;NLG-919;GDC0919;RG6078. 
英文同义词NLG 919;NLG-919;GDC0919;RG6078. 
分子式C18H22N2O 
分子量282.38 
SmileOC(C1CCCCC1)CC(C2=C3C=CC=C2)N4C3=CN=C4
InChiKeyYTRRAUACYORZLX-UHFFFAOYSA-N
InChiInChI=1S/C18H22N2O/c21-18(13-6-2-1-3-7-13)10-16-14-8-4-5-9-15(14)17-11-19-12-20(16)17/h4-5,8-9,11-13,16,18,21H,1-3,6-7,10H2
Cas号1402836-58-1
相关CAS号

订购信息

包装价格库存纯度备货期
大货询价询价询价
Request Bulk Quote Download MSDS 电话 : +86-177 0271 9238   Email : sales@sun-shinechem.com
外观性状crystalline solid 
纯度98% 
存储3 years -20ºCpowder 
可溶性Soluble in DMSO 
处理方式
运输条件Shipped under ambient temperature 
海关编码
Coming soon.
Targets
Mechanism
Cell study
Animal study
Clinical study
Not available

化学结构

52246 - NLG919(GDC0919) | CAS 1402836-58-1

快速订购

Change